22nd Century Group to Host Webcast of 2020 Second Quarter Results
22nd Century Group (NYSE American: XXII) announced a live audio webcast scheduled for August 6, 2020, at 8:00 a.m. ET to discuss its second quarter 2020 results. A press release revealing the results will be issued at 7:00 a.m. ET on the same day. Key executives, including CEO James A. Mish, COO Michael Zercher, and CFO John Franzino, will present during the event. Investors can access the webcast through the company's Investor Relations website, and an archived replay will be available afterward.
- None.
- None.
Insights
Analyzing...
WILLIAMSVILLE, N.Y., July 09, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding, will host a live audio webcast on Thursday, August 6, 2020 at 8:00 a.m. ET to discuss its 2020 second quarter results. 22nd Century Group will issue a press release containing results at 7:00 a.m. ET the same day. The live audio webcast will be accessible in the Events section on the Company's Investor Relations website at www.xxiicentury.com/investors/events.
During the webcast, James A. Mish, Chief Executive Officer; Michael Zercher, Chief Operating Officer; and John Franzino, Chief Financial Officer, will review 2020 second quarter results.
Investors, analysts and members of the media interested in submitting questions in advance can do so by sending an e-mail to investorrelations@xxiicentury.com.
An archived replay of the webcast will also be available shortly after the live event has concluded.
About 22nd Century Group, Inc.
22nd Century Group, Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. The Company’s primary mission in tobacco is to reduce the harm caused by smoking by bringing its proprietary reduced nicotine content tobacco cigarettes – containing
Learn more at xxiicentury.com, on Twitter @_xxiicentury and on LinkedIn.
Contacts:
Mei Kuo
22nd Century Group
(716) 300-1221
mkuo@xxiicentury.com
John Mills
ICR
(646) 277-1254
john.mills@icrinc.com
Deirdre Thomson
ICR
(646) 277-1283
deirdre.thomson@icrinc.com